TUESDAY, June 28, 2016 (HealthDay News) -- The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus (HCV).
www.stltoday.com - RSS Results in lifestyles* of type article, St. Louis Post-Dispatch: Living
Tue, 06/28/2016 - 8:18am
TUESDAY, June 28, 2016 (HealthDay News) -- The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus (HCV).